We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ixico Plc | LSE:IXI | London | Ordinary Share | GB00BFXR4C20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.125 | -1.43% | 8.625 | 8.50 | 8.75 | 8.75 | 8.625 | 8.75 | 6,800 | 16:18:38 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMIXI
RNS Number : 4530V
IXICO plc
30 January 2017
30 January 2017
IXICO plc
("IXICO" or the "Company")
Results of AGM
IXICO plc (AIM: IXI), the brain health company, today announces that that all resolutions put to its Annual General Meeting held earlier today were duly passed.
For further information please contact:
IXICO plc Susan Lowther, Chief Financial Officer and Company Secretary Tel: +44 20 3763 7499 Shore Capital (Nomad and Broker) Bidhi Bhoma / Edward Mansfield Tel: +44 20 7408 4090 FTI Consulting Limited (Investor Relations) Simon Conway/Mo Noonan/Matthew Moss Tel: +44 20 3727 1000
About IXICO
IXICO's innovative and proprietary digital healthcare technologies help those involved in researching and treating serious diseases to capture and analyse clinical data to make rapid, informed decisions. In clinical research this includes the phenotyping of patients, quantification of disease pathology and measurement of patient outcomes. In clinical practice the mobile health and digital decision support technologies aid diagnosis, patient engagement and monitoring. IXICO is also collaborating with partners to develop companion digital health products targeted at improving patient outcomes.
The Company's brain health focus includes Alzheimer's disease, Huntington's disease, multiple sclerosis, Parkinson's disease, behavioural health, child and adolescent mental health.
More information is available on www.ixico.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGOKKDBKBKDKDN
(END) Dow Jones Newswires
January 30, 2017 05:28 ET (10:28 GMT)
1 Year Ixico Chart |
1 Month Ixico Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
